[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.176.107. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 929
Citations 0
News From the Food and Drug Administration
January 19, 2016

Cooling System to Prevent Hair Loss

JAMA. 2016;315(3):243. doi:10.1001/jama.2015.18375

Women with breast cancer who dread losing their hair during chemotherapy have a new ally. The first computer-controlled scalp cooling device designed to reduce the frequency and severity of chemotherapy-induced alopecia has gained FDA approval.

The DigniCap Cooling System, manufactured by Dignitana of Lund, Sweden, circulates liquid coolant throughout a silicone cap that fits snugly over the head. The cap contains 2 sensors that continuously monitor scalp temperature, allowing the system to maintain the optimal cooling level. A third built-in safety sensor prevents scalp temperature from dropping below 32°F. In a clinical study, patients’ scalp temperature was lowered to between 37.4°F and 41°F (Friedrichs K and Carstensen MH. Springerplus. 2014;3:500). An insulating outer cap made of neoprene fits over the silicone cap and keeps it in place while patients receive therapy.

First Page Preview View Large
First page PDF preview
First page PDF preview
×